Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

BACKGROUND: Hematopoieticic stem cell transplantation is the only therapeutic option that can cure thalassemia disease. Reduced intensity hematopoietic stem cell transplantation (RI-HSCT) has demonstrated a high cure rate with minimal complications compared to other options. Because RI-HSCT is very...

Descripción completa

Detalles Bibliográficos
Autores principales: Sruamsiri, Rosarin, Chaiyakunapruk, Nathorn, Pakakasama, Samart, Sirireung, Somtawin, Sripaiboonkij, Nintita, Bunworasate, Udomsak, Hongeng, Suradej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583808/
https://www.ncbi.nlm.nih.gov/pubmed/23379888
http://dx.doi.org/10.1186/1472-6963-13-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583808/
https://www.ncbi.nlm.nih.gov/pubmed/23379888
http://dx.doi.org/10.1186/1472-6963-13-45

Ejemplares similares